Skip to content

Clinical trials

Recurrence trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Country / region: Australia Clear all

195 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20044
20051
20063
20072
20084
20095
20106
20116
20124
20136
201410
20159
20167
201717
20188
201910
20207
202111
202212
202320
202415
202512
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed83
Recruiting45
Terminated34
Active, not recruiting25
Unknown status4
Withdrawn2
No longer available1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals17
AbbVie13
AstraZeneca9
Celgene9
Amgen7
Children's Oncology Group7
Peter MacCallum Cancer Centre, Australia7
Pfizer7
Therapeutic Advances in Childhood Leukemia Consortium7
Genmab4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence195
Multiple Myeloma43
Neoplasms28
Lymphoma22
Leukemia20
Lymphoma, Non-Hodgkin18
Leukemia, Myeloid, Acute17
Neoplasm Metastasis17
Precursor Cell Lymphoblastic Leukemia-Lymphoma14
Lymphoma, Large B-Cell, Diffuse13

Trials

Showing 76 to 100 of 195. Each trial links to its page on Pharma Observatory.

95 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.